Cargando…
Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients
As the prognosis of metastatic non-small cell lung cancer (NSCLC) patients is constantly improving with advances in systemic therapies (immune checkpoint blockers and new generation of targeted molecular compounds), more attention should be paid to the diagnosis and management of treatments-related...
Autores principales: | Loganadane, Gokoulakrichenane, Dhermain, Frédéric, Louvel, Guillaume, Kauv, Paul, Deutsch, Eric, Le Péchoux, Cécile, Levy, Antonin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134016/ https://www.ncbi.nlm.nih.gov/pubmed/30234011 http://dx.doi.org/10.3389/fonc.2018.00336 |
Ejemplares similares
-
Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2018) -
Thoracic radiotherapy in small cell lung cancer—a narrative review
por: Levy, Antonin, et al.
Publicado: (2021) -
Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?
por: Sun, Roger, et al.
Publicado: (2017) -
Tumour motion management in lung cancer: a narrative review
por: Botticella, Angela, et al.
Publicado: (2021) -
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients
por: Boros, Angela, et al.
Publicado: (2017)